A randomized trial comparing cisplatin plus cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancer
Article
Overview
publication date
published in
Identity
Scopus Document Identifier
Digital Object Identifier (DOI)
-
10.1097/00006254-198706000-00021
Additional Document Info
volume
issue